The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...

The US Food and Drug Administration (FDA) has approved an expanded indication for onabotulinum toxin A (Botox, Actavis) for the treatment of adults with upper limb spasticity, according to a company ...

Label updates include addition of two thumb flexor muscles and increased maximum cumulative dose DUBLIN, April 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), which recently completed the ...

-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...

The UAB Department of Orthopaedic Surgery Hand and Upper Extremity Section specializes in the research, education, diagnosis, and treatment of a spectrum of disorders and injuries of the upper ...

LIVINGSTON, United Kingdom & MANSFIELD, Mass., Apr 11, 2013 (BUSINESS WIRE) -- Touch Bionics, a provider of world-leading prosthetic technologies, today announced a significant advance to the ...

Current clinical assessments evaluating selective voluntary motor control are measured on an ordinal scale. We combined the Selective Control of the Upper Extremity Scale (SCUES) with surface ...

The UAB Hand and Upper Extremity Fellowship provides comprehensive training in hand, upper extremity, and nerve surgery during a one-year ACGME-accredited Hand Surgery Fellowship program. This is a ...

Osteogenesis Imperfecta (OI) is a heritable disorder characterized by increased bone fragility. In OI Type IV muscle weakness has important functional consequences. Children and adolescents with OI ...

- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...